Legal & General Group’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$740K Sell
35,375
-4,055
-10% -$56.4K ﹤0.01% 2241
2025
Q4
$349K Buy
39,430
+32,985
+512% +$284K ﹤0.01% 2505
2025
Q3
$54.1K Sell
6,445
-540
-8% -$3.65K ﹤0.01% 2717
2025
Q2
$35.8K Buy
6,985
+1,640
+31% +$4.05K ﹤0.01% 2784
2025
Q1
$7.32K Sell
5,345
-32,616
-86% -$80.1K ﹤0.01% 3225
2024
Q4
$117K Hold
37,961
﹤0.01% 2709
2024
Q3
$292K Sell
37,961
-120
-0.3% -$1.15K ﹤0.01% 2614
2024
Q2
$327K Buy
38,081
+1,674
+5% +$12.9K ﹤0.01% 2571
2024
Q1
$289K Hold
36,407
﹤0.01% 2613
2023
Q4
$360K Sell
36,407
-3,515
-9% -$30.5K ﹤0.01% 2573
2023
Q3
$450K Sell
39,922
-652
-2% -$3.98K ﹤0.01% 2478
2023
Q2
$135K Buy
40,574
+21,883
+117% +$78.7K ﹤0.01% 2807
2023
Q1
$73.8K Buy
18,691
+1,223
+7% +$7.1K ﹤0.01% 2820
2022
Q4
$127K Buy
17,468
+5,889
+51% +$41.4K ﹤0.01% 2760
2022
Q3
$42K Buy
11,579
+3,935
+51% +$16.8K ﹤0.01% 3015
2022
Q2
$35K Sell
7,644
-3,753
-33% -$22.7K ﹤0.01% 3078
2022
Q1
$86K Hold
11,397
﹤0.01% 2902
2021
Q4
$125K Buy
+11,397
New +$137K ﹤0.01% 2861

Other funds holding TNGX